摘要
目的:通过研究P16蛋白表达与胃癌发生及胃癌临床病理因素的关系,以探讨检测P16蛋白在胃癌诊断及判断胃癌恶性程度、估计预后和指导临床治疗的临床病理学意义。方法:采用免疫组化S-P法,检测100例胃癌与20例正常胃黏膜组织中P16蛋白表达情况。结果:P16蛋白在胃癌中表达率(36.0%)明显低于正常胃黏膜组织(85.0%)(P<0.01);P16蛋白表达与肉眼类型、分化程度、浸润深度、淋巴结转移,TNM分期有关(P<0.05);P16蛋白表达与患者性别、年龄、原发灶部位无关(P>0.05)。结论:检测P16蛋白的表达对辅助胃癌的诊断有很高的价值,并可作为判断胃癌恶性程度、估计预后和指导临床治疗的临床病理参考指标。
Objective: To study the relations between the expression of P16 and the genesis of gastric carcinoma and the clinico-pathological characteristics of gastric carcinoma, and to investigate the clinicopathological significance of detection P16 on diagnosis of gastric carcinoma, degree of malignant, prognostic appreciation and clinical treatment. Methods: Expressions of P16 were examined by S-P immunohistochemical staining in 20 cases of normal gastric mucosas and 100 cases of gastric carcinoma. Results: The positive rate of P16 expression in gastric carcinoma was 36.0%, lower than that in nomal gastric mucosas (85.0%)( P 〈0.01); it is related to the differ- entiation, invasion, metastasis by lymphatics, and staging of TNM (P 〈0.05), but has nothing to do with sex, age, and situs of affection (P〉0.05). Conclusions: The detection of P16 is highly valued to diagnose gastric carcinoma and to evaluate the degree of malignant, prognostic appreciation and clinical treatment on gastric carcinoma.
出处
《现代生物医学进展》
CAS
2009年第2期292-294,314,共4页
Progress in Modern Biomedicine
基金
安徽省教育厅自然科学研究重点项目(编号:2006KJ100A)
关键词
胃癌
P16蛋白
免疫组织化学
Gastric carcinoma
P16 protein
Immunohistochemistry